Patents by Inventor Takehiro Yatomi

Takehiro Yatomi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating graft versus host disease by administration of a Fas antagonist
    Patent number: 7128905
    Abstract: The present invention is drawn to methods of preventing and treating diseases wherein the involvement of apoptosis has been indicated.
    Type: Grant
    Filed: February 28, 2002
    Date of Patent: October 31, 2006
    Assignees: Mochida Pharmaceutical Co., Ltd., Osaka Bioscience Institute
    Inventors: Shigekazu Nagata, Takehiro Yatomi, Takashi Suda
  • Preventives/remedies for autoimmune demyelinating diseases
    Patent number: 6759041
    Abstract: The present invention is drawn to a method for treating autoimmune demyelinating diseases by administering to a patient in need thereof an effective amount of a Fas antagonist. The method of the present invention uses, for example, as a Fas antagonist a substance which suppresses Fas-Fas ligand binding.
    Type: Grant
    Filed: November 29, 2000
    Date of Patent: July 6, 2004
    Assignee: Mochida Pharmaceutical Co., Ltd.
    Inventor: Takehiro Yatomi
  • Prophylactic/therapeutic agent
    Publication number: 20030109416
    Abstract: The present invention is drawn to methods of preventing and treating diseases wherein the involvement of apoptosis has been indicated.
    Type: Application
    Filed: February 28, 2002
    Publication date: June 12, 2003
    Applicants: Mochida Pharmaceutical Co., Ltd., Osaka Bioscience Institute
    Inventors: Shigekazu Nagata, Takehiro Yatomi, Takashi Suda
  • Preventives/remedies for inflammatory intestinal disease
    Patent number: 6562342
    Abstract: Preventives/remedies for at least one disease selected from the group consisting of inflammatory intestinal disease, ischemic colitis and idiopathic inflammatory intestinal disease induced by infection, chemicals and radiation which contain as the active ingredient an anti-Fas ligand antibody; and preventives and remedies with the use of the same.
    Type: Grant
    Filed: August 2, 2000
    Date of Patent: May 13, 2003
    Assignees: Mochida Pharmaceutical Co., Ltd., Osaka Bioscience Institute
    Inventors: Takehiro Yatomi, Shigekazu Nagata, Takashi Suda